Get startedLog in
    Picture of Daesung Microbiological Labs Co logo

    036480 — Daesung Microbiological Labs Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Daesung Microbiological Labs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsARSAnnual Audited AccountsAnnual Audited AccountsARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1,5198661,703-680-1,769
    Depreciation
    Amortisation
    Non-Cash Items1,309453-9197031,655
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1,539-1,654-2,335-4,120503
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities3,2362,2031,155-1,2342,103
    Capital Expenditures-14,444-2,969-2,315-1,260-796
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1,128-6721,1571,4962,215
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities-15,572-3,641-1,1582361,419
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities9,558305-6461,481-4,477
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-3,040-817-543511-732